Informal Request for ATI Records Previously Released

Organization: Health Canada

Year: 2020

Month: August

Request Number: A-2020-000015

Request Summary: Information as to whether or not the Abbreviated New Drug Submission (ANDS) for liraglutide accepted into review in August 2017 is on “intellectual property hold” as described in section 6.2 of Health Canada’s Guidance Document on PatentedMedicines (Notice of Compliance) Regulations.

Disposition: All disclosed

Number of pages: 1

Date modified: